• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 NOD/LtSz-scid IL2Rγnull 小鼠体内成功建立了肝母细胞瘤原位模型。

Successful establishment of an orthotopic hepatoblastoma in vivo model in NOD/LtSz-scid IL2Rγnull mice.

机构信息

Department of Pediatric Surgery, Children's University Hospital Tuebingen, Tuebingen, Germany.

出版信息

PLoS One. 2011;6(8):e23419. doi: 10.1371/journal.pone.0023419. Epub 2011 Aug 10.

DOI:10.1371/journal.pone.0023419
PMID:21853130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3154467/
Abstract

Investigation of hepatoblastoma in experimental conditions contributes relevantly to a detailed understanding of tumor biology and the investigation of new treatment approaches. Most systematical analyses currently use subcutaneous xenografts. We established a reproducible intrahepatic model with the hepatoblastoma-cell lines HuH6 and HepT1. The cells were stably transfected with a plasmid vector encoding for Gaussia luciferase. HuH6 and HepT1 were injected intrasplenically in NOD/LtSz-scid IL2Rγnull mice. Mice were splenectomized in order to avoid intrasplenical tumor growth. Multifocal intrahepatic tumor growth was observed in 85% (11/13) of HuH6 tumors and 55% (5/9) of HepT1 tumors. Serum Alpha-fetoprotein and Gaussia luciferase increased 5 weeks after tumor-cell inoculation. Tumors were detected by MRI at this time point. Immunhistochemical analysis such as vascularity (CD31), proliferation index (Ki-67), cytokeratin 7 and distribution of β-catenin in intrahepatic tumors were different to subcutaneous tumors. We established a reproducible xenograft model for intrahepatic hepatoblastoma growth with a high tumor incidence. Monitoring of tumor cell viability was optimized by measuring GLuc. This model enables further experimental investigations of HB in a more physiological milieu as emphasized by the β-catenin distribution.

摘要

在实验条件下研究肝母细胞瘤对深入了解肿瘤生物学和研究新的治疗方法有重要贡献。目前大多数系统分析都使用皮下异种移植。我们用肝母细胞瘤细胞系 HuH6 和 HepT1 建立了一种可重复的肝内模型。这些细胞被稳定地转染了一个编码 Gaussia 荧光素酶的质粒载体。HuH6 和 HepT1 被注射到 NOD/LtSz-scid IL2Rγnull 小鼠的脾内。为了避免脾内肿瘤生长,对小鼠进行了脾切除术。在 HuH6 肿瘤的 85%(11/13)和 HepT1 肿瘤的 55%(5/9)中观察到多灶性肝内肿瘤生长。在肿瘤细胞接种后 5 周,血清甲胎蛋白和 Gaussia 荧光素酶增加。此时可以通过 MRI 检测到肿瘤。肝内肿瘤的免疫组织化学分析,如血管生成(CD31)、增殖指数(Ki-67)、细胞角蛋白 7 和 β-连环蛋白的分布,与皮下肿瘤不同。我们建立了一种可重复的肝内肝母细胞瘤生长的异种移植模型,肿瘤发生率很高。通过测量 GLuc 优化了肿瘤细胞活力的监测。该模型使我们能够在更生理的环境中进一步研究 HB,β-连环蛋白的分布强调了这一点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1802/3154467/cff1fa5355d3/pone.0023419.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1802/3154467/7bafb09386b0/pone.0023419.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1802/3154467/c68e1c335efe/pone.0023419.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1802/3154467/5b38a69111e5/pone.0023419.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1802/3154467/6c53eb60bbb2/pone.0023419.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1802/3154467/3637ac2f2194/pone.0023419.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1802/3154467/cff1fa5355d3/pone.0023419.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1802/3154467/7bafb09386b0/pone.0023419.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1802/3154467/c68e1c335efe/pone.0023419.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1802/3154467/5b38a69111e5/pone.0023419.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1802/3154467/6c53eb60bbb2/pone.0023419.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1802/3154467/3637ac2f2194/pone.0023419.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1802/3154467/cff1fa5355d3/pone.0023419.g006.jpg

相似文献

1
Successful establishment of an orthotopic hepatoblastoma in vivo model in NOD/LtSz-scid IL2Rγnull mice.在 NOD/LtSz-scid IL2Rγnull 小鼠体内成功建立了肝母细胞瘤原位模型。
PLoS One. 2011;6(8):e23419. doi: 10.1371/journal.pone.0023419. Epub 2011 Aug 10.
2
Subcutaneous and intrahepatic growth of human hepatoblastoma in immunodeficient mice.人肝母细胞瘤在免疫缺陷小鼠体内的皮下及肝内生长
J Hepatol. 2006 Sep;45(3):377-86. doi: 10.1016/j.jhep.2006.03.018. Epub 2006 May 3.
3
Increased efficacy of CDDP in a xenograft model of hepatoblastoma using the apoptosis sensitizer ABT-737.使用凋亡敏化剂 ABT-737 提高肝癌异种移植模型中 CDDP 的疗效。
Oncol Rep. 2013 Feb;29(2):646-52. doi: 10.3892/or.2012.2150. Epub 2012 Nov 27.
4
The BH3 mimetic ABT-737 increases treatment efficiency of paclitaxel against hepatoblastoma.BH3 模拟物 ABT-737 提高紫杉醇治疗肝癌的疗效。
BMC Cancer. 2011 Aug 19;11:362. doi: 10.1186/1471-2407-11-362.
5
Hepatoblastoma cells express truncated neurokinin-1 receptor and can be growth inhibited by aprepitant in vitro and in vivo.肝癌细胞表达截断的神经激肽-1 受体,阿瑞匹坦可在体外和体内抑制其生长。
J Hepatol. 2014 May;60(5):985-94. doi: 10.1016/j.jhep.2013.12.024. Epub 2014 Jan 8.
6
A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma.基于新型细胞系的原位异种移植小鼠模型可重现人类肝母细胞瘤。
Sci Rep. 2017 Dec 19;7(1):17751. doi: 10.1038/s41598-017-17665-8.
7
Development of a drug resistance model for hepatoblastoma.建立肝癌耐药模型。
Int J Oncol. 2011 Feb;38(2):447-54. doi: 10.3892/ijo.2010.860. Epub 2010 Dec 3.
8
Characterization of the continuous cell line HepT1 derived from a human hepatoblastoma.源自人肝母细胞瘤的连续细胞系HepT1的特性分析。
Lab Invest. 1996 Apr;74(4):809-18.
9
Pharmacological inhibition of beta-catenin in hepatoblastoma cells.肝母细胞瘤细胞中β-连环蛋白的药理学抑制作用。
Pediatr Surg Int. 2013 Feb;29(2):141-9. doi: 10.1007/s00383-012-3237-9. Epub 2012 Dec 25.
10
BH3-mimetic drugs prevent tumour onset in an orthotopic mouse model of hepatoblastoma.BH3 模拟药物可预防肝母细胞瘤原位小鼠模型中的肿瘤发生。
Exp Cell Res. 2014 Mar 10;322(1):217-25. doi: 10.1016/j.yexcr.2013.12.007. Epub 2013 Dec 16.

引用本文的文献

1
Intratumoral Heterogeneity and Immune Microenvironment in Hepatoblastoma Revealed by Single-Cell RNA Sequencing.单细胞RNA测序揭示的肝母细胞瘤瘤内异质性和免疫微环境
J Cell Mol Med. 2025 Mar;29(6):e70482. doi: 10.1111/jcmm.70482.
2
Modelling the impact of liver regeneration on hepatoblastoma patient-derived-xenograft tumor growth.模拟肝再生对肝母细胞瘤患者来源异种移植瘤生长的影响。
Pediatr Res. 2024 Aug;96(3):668-677. doi: 10.1038/s41390-024-03020-x. Epub 2024 Jan 23.
3
Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma.

本文引用的文献

1
Detection of human hematopoietic stem cell engraftment in the livers of adult immunodeficient mice by an optimized flow cytometric method.通过优化的流式细胞术方法检测成年免疫缺陷小鼠肝脏中的人造血干细胞植入情况。
Stem Cell Stud. 2010 Nov 23;1(1). doi: 10.4081/scs.2010.e5.
2
Application of magnetic resonance imaging in transgenic and chemical mouse models of hepatocellular carcinoma.磁共振成像在肝癌转基因和化学诱导小鼠模型中的应用。
Mol Cancer. 2010 Apr 29;9:94. doi: 10.1186/1476-4598-9-94.
3
Three agonist antibodies in combination with high-dose IL-2 eradicate orthotopic kidney cancer in mice.
高危肝母细胞瘤中癌症相关基因和化疗遗传修饰体的全基因组图谱绘制。
Nat Commun. 2023 Jul 6;14(1):4003. doi: 10.1038/s41467-023-39717-6.
4
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells.源自HepT1的高危肝母细胞瘤小鼠模型表现出血管侵袭、转移和循环肿瘤细胞。
Biol Open. 2022 Sep 15;11(9). doi: 10.1242/bio.058973. Epub 2022 Sep 12.
5
Current Approaches in Hepatoblastoma-New Biological Insights to Inform Therapy.当前肝癌治疗方法的新生物学见解。
Curr Oncol Rep. 2022 Sep;24(9):1209-1218. doi: 10.1007/s11912-022-01230-2. Epub 2022 Apr 19.
6
Identification of distinct tumor cell populations and key genetic mechanisms through single cell sequencing in hepatoblastoma.通过单细胞测序鉴定肝母细胞瘤中不同的肿瘤细胞群体和关键遗传机制。
Commun Biol. 2021 Sep 8;4(1):1049. doi: 10.1038/s42003-021-02562-8.
7
Animal Modeling of Pediatric Liver Cancer.小儿肝癌的动物模型
Cancers (Basel). 2020 Jan 22;12(2):273. doi: 10.3390/cancers12020273.
8
Tracking cellular and molecular changes in a species-specific manner during experimental tumor progression .在实验性肿瘤进展过程中以物种特异性方式追踪细胞和分子变化。
Oncotarget. 2018 Mar 1;9(22):16149-16162. doi: 10.18632/oncotarget.24598. eCollection 2018 Mar 23.
9
A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma.基于新型细胞系的原位异种移植小鼠模型可重现人类肝母细胞瘤。
Sci Rep. 2017 Dec 19;7(1):17751. doi: 10.1038/s41598-017-17665-8.
10
Novel Advances in Understanding of Molecular Pathogenesis of Hepatoblastoma: A Wnt/β-Catenin Perspective.肝母细胞瘤分子发病机制认识的新进展:基于Wnt/β-连环蛋白的视角
Gene Expr. 2017 Feb 10;17(2):141-154. doi: 10.3727/105221616X693639. Epub 2016 Nov 2.
三种激动剂抗体与高剂量 IL-2 联合使用可根除小鼠原位肾癌。
J Transl Med. 2010 Apr 28;8:42. doi: 10.1186/1479-5876-8-42.
4
Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.成功治疗儿童高危肝母细胞瘤的剂量密集型多药化疗和手术:SIOPEL-3HR 研究的最终结果。
J Clin Oncol. 2010 May 20;28(15):2584-90. doi: 10.1200/JCO.2009.22.4857. Epub 2010 Apr 20.
5
Secreted Gaussia luciferase as a biomarker for monitoring tumor progression and treatment response of systemic metastases.分泌型海肾荧光素酶作为一种生物标志物,用于监测系统性转移的肿瘤进展和治疗反应。
PLoS One. 2009 Dec 15;4(12):e8316. doi: 10.1371/journal.pone.0008316.
6
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.顺铂与顺铂加阿霉素治疗标准风险肝母细胞瘤的比较。
N Engl J Med. 2009 Oct 22;361(17):1662-70. doi: 10.1056/NEJMoa0810613.
7
Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model.Wnt 信号与肝癌发生:肝母细胞瘤模型。
Int J Biochem Cell Biol. 2011 Feb;43(2):265-70. doi: 10.1016/j.biocel.2009.07.012. Epub 2009 Jul 29.
8
Wnt/beta-catenin signaling: components, mechanisms, and diseases.Wnt/β-连环蛋白信号传导:组成部分、机制及相关疾病
Dev Cell. 2009 Jul;17(1):9-26. doi: 10.1016/j.devcel.2009.06.016.
9
Noninvasive monitoring of a murine model of metastatic pheochromocytoma: a comparison of contrast-enhanced microCT and nonenhanced MRI.转移性嗜铬细胞瘤小鼠模型的无创监测:对比增强微型计算机断层扫描与非增强磁共振成像的比较
J Magn Reson Imaging. 2009 Mar;29(3):685-91. doi: 10.1002/jmri.21654.
10
Redefining the role of doxorubicin for the treatment of children with hepatoblastoma.重新定义阿霉素在儿童肝母细胞瘤治疗中的作用。
J Clin Oncol. 2008 May 10;26(14):2379-83. doi: 10.1200/JCO.2006.09.7204.